Development of drug resistance in a murine mammary tumour.

Por McMillan, T. J., Stephens, T. C., Steel, G. G.
Publicado em 1985

Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity

Por Qingjie Guo, Qingjie Guo, Ruonan Zheng, Jiarui Huang, Meng He, Yuhan Wang, Zonghao Guo, Liankun Sun, Peng Chen, Peng Chen
Publicado em 2018-12-01

Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity

Por Guo, Qingjie, Zheng, Ruonan, Huang, Jiarui, He, Meng, Wang, Yuhan, Guo, Zonghao, Sun, Liankun, Chen, Peng
Publicado no Front Genet (2018)

Corrigendum: Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity

Por Qingjie Guo, Qingjie Guo, Ruonan Zheng, Jiarui Huang, Meng He, Yuhan Wang, Zonghao Guo, Liankun Sun, Peng Chen, Peng Chen
Publicado em 2019-06-01

Corrigendum: Using Integrative Analysis of DNA Methylation and Gene Expression Data in Multiple Tissue Types to Prioritize Candidate Genes for Drug Development in Obesity

Por Guo, Qingjie, Zheng, Ruonan, Huang, Jiarui, He, Meng, Wang, Yuhan, Guo, Zonghao, Sun, Liankun, Chen, Peng
Publicado no Front Genet (2019)

Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical Trials

Por Hansen, Aaron R., Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L., Hinrichs, Mary Jane
Publicado no Oncologist (2015)

Pharmacokinetics and Drug Dosing in Obese Children

Por Kendrick, Jennifer G., Carr, Roxane R., Ensom, Mary H.H.
Publicado em 2010

Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents

Por Yuan, Mingjun, Chua, Song Lin, Liu, Yang, Drautz-Moses, Daniela I, Yam, Joey Kuok Hoong, Aung, Thet Tun, Beuerman, Roger W, Salido, May Margarette Santillan, Schuster, Stephan C, Tan, Choon-Hong, Givskov, Michael, Yang, Liang, Nielsen, Thomas E
Publicado no Beilstein J Org Chem (2018)

Testing for Drug Hypersensitivity Syndromes

Por Rive, Craig M, Bourke, Jack, Phillips, Elizabeth J
Publicado em 2013

A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors

Por Leong, Stephen, Moss, Rebecca A., Bowles, Daniel W., Ware, Joseph A., Zhou, Jing, Spoerke, Jill M., Lackner, Mark R., Shankar, Geetha, Schutzman, Jennifer L., van der Noll, Ruud, Voest, Emile E., Schellens, Jan H.M.
Publicado no Oncologist (2017)

Development of Potent Antiviral Drugs Inspired by Viral Hexameric DNA-Packaging Motors with Revolving Mechanism

Por Pi, Fengmei, Zhao, Zhengyi, Chelikani, Venkata, Yoder, Kristine, Kvaratskhelia, Mamuka, Guo, Peixuan
Publicado no J Virol (2016)

Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?

Por Martorana, Alessandro, Esposito, Zaira, Koch, Giacomo
Publicado no CNS Neurosci Ther (2010)

Short Communication: A Repeated Simian Human Immunodeficiency Virus Reverse Transcriptase/Herpes Simplex Virus Type 2 Cochallenge Macaque Model for the Evaluation of Microbicides

Por Kenney, Jessica, Derby, Nina, Aravantinou, Meropi, Kleinbeck, Kyle, Frank, Ines, Gettie, Agegnehu, Grasperge, Brooke, Blanchard, James, Piatak, Michael, Lifson, Jeffrey D., Zydowsky, Thomas M., Robbiani, Melissa
Publicado em 2014

Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development

Por Ahrén, Bo
Publicado no J Diabetes Investig (2018)

Development of a mobile application for vancomycin dosing calculation: A useful tool for the rational use of antimicrobials

Por Tácio de Mendonça Lima, Millena Padela da Silva, Luan Donato Silva Luz, Thais Cristina Amorim Estevão Soares, Etielle Silvestre Dantas, Gabriela Felix Teixeira, Rafael Henrique de Souza Costa, Sérgio Henrique Monte Santo Andrade
Publicado em 2022-03-01

Significant Differences in the Development of Acquired Resistance to the MDM2 Inhibitor SAR405838 between In Vitro and In Vivo Drug Treatment

Por Hoffman-Luca, C. Gianna, Yang, Chao-Yie, Lu, Jianfeng, Ziazadeh, Daniel, McEachern, Donna, Debussche, Laurent, Wang, Shaomeng
Publicado no PLoS One (2015)

DNA Damage Response in Neonatal and Adult Stromal Cells Compared With Induced Pluripotent Stem Cells

Por Liedtke, Stefanie, Biebernick, Sophie, Radke, Teja Falk, Stapelkamp, Daniela, Coenen, Carolin, Zaehres, Holm, Fritz, Gerhard, Kogler, Gesine
Publicado no Stem Cells Transl Med (2015)

Reversal of Acquired Drug Resistance in FLT3-mutated Acute Myeloid Leukemia Cells via Distinct Drug Combination Strategies

Por Zhang, Weiguo, Gao, Chen, Konopleva, Marina, Chen, Ye, Jacamo, Rodrigo O., Borthakur, Gautam, Cortes, Jorge E., Ravandi, Farhad, Ramachandran, Abhijit, Andreeff, Michael
Publicado em 2014

Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs

Por Bazhulina, N.P., Surovaya, A.N., Gursky, Y.G., Andronova, V.L., Moiseeva, E.D., Nikitin, A.M., Golovkin, M.V., Galegov, G.A., Grokhovsky, S.L., Gursky, G.V.
Publicado em 2013

Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations

Por Zeng, Yaohui, Singh, Sachinkumar, Wang, Kai, Ahrens, Richard C.
Publicado no J Clin Pharmacol (2017)